Article
Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.
Apoptosis : an international journal on programmed cell death - 21 Aug 2026
Chakraborty Sourio, Mukherjee Sumon, Ghosh Subhajit, Basak Udit, Mukherjee Sumoyee, Adhikary Arghya, Sa Gaurisankar, Das Tanya
Abstract excerpt
The efficacy of cancer immunotherapy depends on the inherent immunogenicity of tumor cells, which is their ability to display recognizable antigens and stimulate effective immune responses. However, the immunogenic landscape of cancer is not static; it evolves through cancer immunoediting, a dynamic process that refines tumor antigenicity and sculpts immune evasion mechanisms. This immunogenic reprogramming often...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.